BROOKE SIMAS: Open Payments
NPI 1053084285 · NATICK, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 19 payments from 12 companies in 2025. Trend: 2023 $251 · 2024 $301 · 2025 $507
Food & beverage: $408Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $100 |
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Janssen Biotech, Inc. | 1 | $36 |
| GENZYME CORPORATION | 1 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $33 |
| Galderma Laboratories, L.P. | 2 | $33 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $32 |
| Botanix SB Inc | 1 | $23 |
Products named: DUPIXENT, SKYRIZI, Sotyktu, Rhapsido, TREMFYA, VALCHLOR, RINVOQ, SOFDRA.
Industry payments across MA — which companies pay providers there.
